Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

2.32
+0.04542.00%
Volume:30.38K
Turnover:68.86K
Market Cap:1.85M
PE:-0.02
High:2.32
Open:2.25
Low:2.20
Close:2.27
52wk High:136.29
52wk Low:2.20
Shares:798.40K
Float Shares:759.70K
Volume Ratio:0.35
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.06
PE(LYR):0.00

Loading ...

Glucotrack Regains NASDAQ Stockholders’ Equity Compliance, Secures Continued Listing

Reuters
·
Aug 17

GlucoTrack Achieves Key Compliance Milestone and Advances Strategic Transformation

THOMSON REUTERS
·
Aug 17

GlucoTrack FY26 Q2 Net Loss Narrows 19.8% to USD 3.81 Million

Reuters
·
Aug 15

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 11

GlucoTrack - Enters Amendment No. 1 to Stock Purchase Agreement with White Lion Capital on Aug 7TH - SEC Filing

THOMSON REUTERS
·
Aug 11

GlucoTrack to Issue 2,505,513 Unregistered Shares to White Lion Capital Under Stock Purchase Agreement Amendment

Reuters
·
Aug 11

GlucoTrack Prices $2 Million Registered Direct Offering at $0.75 Per Unit

Reuters
·
Aug 05

GlucoTrack Announces $5.5 Million Financing

THOMSON REUTERS
·
Aug 05

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 01

GlucoTrack announces expansion of ai Futures Lab

TIPRANKS
·
Jul 31

GlucoTrack Unit Lokahi Therapeutics Expands Ai2 Futures Lab to 12 University Partnerships

Reuters
·
Jul 31

NASDAQ Trade Halt Volatility Trading Pause at 03:18 Pm

Reuters
·
Jul 31

Top Premarket Gainers

MT Newswires Live
·
Jul 30

GlucoTrack Unit Lokahi Therapeutics Targets Single-shot Lt-100 Dosing in Planned Q4 2026 Trial

Reuters
·
Jul 30

GlucoTrack Amends 8-K to Update Terms of $900,000 Note-for-shares Exchange Agreement

Reuters
·
Jul 30

Lokahi Therapeutics: Anticipates Clinical Evaluation of Single-Injection Lt-100 as Early as Q4 2026

THOMSON REUTERS
·
Jul 30

LŌKahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration

THOMSON REUTERS
·
Jul 30

GlucoTrack Enters Exchange Deal on $900,000 Promissory Note with Investor

Reuters
·
Jul 28

E.f. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

THOMSON REUTERS
·
Jul 18

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.f. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

THOMSON REUTERS
·
Jul 17